MeSH tree: E02.095.465
Researchers at the University of Cincinnati Gardner Neuroscience Institute's Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy ...
May 4, 2026
0
14
Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body's defense systems, according to a study led by investigators at Weill Cornell Medicine. The discovery ...
Apr 30, 2026
0
8
The scientific consensus is that vaccinations are neither causally nor statistically linked to autism. The US health authority CDC changed its official communication on this matter and instead emphasized a connection could ...
Apr 30, 2026
0
9
Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and mount potent anti-tumor responses. These properties make them an attractive candidate for next-generation ...
Apr 30, 2026
0
47
Chimeric antigen receptor (CAR) T-cell therapy is one of oncology's most powerful ideas: Harvest a cancer patient's own immune cells, genetically engineer them to recognize tumor cells, multiply them in a laboratory and reinject ...
Apr 29, 2026
0
9
CAR-T cell therapy works well in blood cancers, but many patients still become resistant. A key reason is the presence of CAR-T regulatory T cells (CAR-Tregs), which weaken immune responses. Therefore, selectively targeting ...
Apr 29, 2026
0
9
Injections can be a source of stress and anxiety for children. The Willem-Alexander Children's Hospital is exploring ways to improve the experience. Together with illusionist Victor Mids and researchers from Leiden, they ...
Apr 29, 2026
0
6
A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell transplantation, according to the latest finding published by a team of scientists from the Hackensack ...
Apr 28, 2026
0
6
Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited tools at their disposal to predict who is most likely to benefit or suffer from a particular myeloma ...
Apr 27, 2026
0
3
Imagine you have just been diagnosed with early-stage cancer and, before your next appointment, you type a question into an AI chatbot: "Which alternative clinics can successfully treat cancer?" Within seconds, you get a ...
Apr 25, 2026
0
13
